Related Experiment Video
Updated: Sep 13, 2026

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
Published on: February 21, 2018
TGF-beta and its receptor complex in leukemic B-cell precursors
C Buske1, D Becker, M Feuring-Buske
1Department of Hematology and Oncology, University of Göttingen, Germany.
Abstract:
Transforming growth factor beta (TGF-beta) is a highly conserved peptide with growth-inhibitory activity in multiple normal and transformed cell types. Signal transduction is mediated through the receptor complex, consisting of two active seronine or threonine kinases (TGF-beta-receptor I and II) and the receptor-associated proteins betaglycan (TGF-beta-receptor III) and endoglin. In this study, we assessed the analysis of the role of TGF-beta and the transcription of the genes for TGF-beta and its receptor in highly purified leukemic B-cell precursors (BCPs) of patients with common acute lymphoblastic leukemia (cALL). Leukemic BCPs were positive for gene transcription of TGF-beta (9/9), the TGF-beta-receptor I (9/9), the TGF-beta-receptor II (6/6), betaglycan (5/6), and endoglin (6/6). Incubation with TGF-beta significantly reduced the cell viability of leukemic BCPs by a mean of 45% (p = 0.0009). The reduction of cell viability was associated with the induction of apoptosis by a mean of 31%. TGF-beta caused significant suppression of the S phase (p = 0.002) and accumulation in the G0/G1 phase (p = 0.0005). It also reduced expression of the adhesion surface receptor CD18 and the Fas antigen CD95 from 58% to 40% and from 48% to 27%, respectively. The data indicate that TGF-beta is a negative growth signal in leukemic BCPs and point to an additional role of TGF-beta as an immunomodulatory cytokine, suggesting a complex role of TGF-beta in the leukemogenesis of cALL.
Insights
Transforming growth factor beta (TGF-beta) inhibits growth and induces apoptosis in common acute lymphoblastic leukemia (cALL) B-cell precursors. This suggests TGF-beta plays a complex role in cALL leukemogenesis and immune modulation.
Area of Science:
- Molecular Biology
- Cell Biology
- Immunology
Background:
- Transforming growth factor beta (TGF-beta) is a conserved peptide with known growth-inhibitory functions.
- TGF-beta signaling involves a receptor complex including TGF-beta-receptor I, II, betaglycan (TGF-beta-receptor III), and endoglin.
- Common acute lymphoblastic leukemia (cALL) involves malignant B-cell precursors (BCPs).
Purpose of the Study:
- To investigate the role of TGF-beta in leukemic BCPs from cALL patients.
- To analyze the gene transcription of TGF-beta and its receptors in these cells.
- To determine the effects of TGF-beta on BCP viability, cell cycle, and surface marker expression.
Main Methods:
- Purification of leukemic BCPs from cALL patients.
- Gene transcription analysis for TGF-beta and its receptor components.
- In vitro incubation of BCPs with TGF-beta.
- Assessment of cell viability, apoptosis, cell cycle phase distribution (G0/G1, S phase), and surface receptor expression (CD18, CD95).
Main Results:
- Leukemic BCPs consistently expressed genes for TGF-beta and its receptors (TGF-beta-receptor I, TGF-beta-receptor II, betaglycan, endoglin).
- TGF-beta treatment significantly reduced BCP viability by 45% and induced apoptosis by 31%.
- TGF-beta suppressed S phase, increased G0/G1 phase accumulation, and decreased expression of CD18 and CD95.
Conclusions:
- TGF-beta acts as a negative growth signal for leukemic BCPs in cALL.
- TGF-beta exhibits immunomodulatory effects by reducing CD18 and CD95 expression.
- TGF-beta likely plays a complex role in cALL leukemogenesis and immune evasion.
Related Concept Videos
Enzyme-linked Receptors
TGF - β Signaling Pathway
Activation and Inactivation of G Proteins
Intracellular Signaling Affects Focal Adhesions
Some...
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...

